These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9308741)

  • 1. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis.
    Hillarp A; Zöller B; Svensson PJ; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):990-2. PubMed ID: 9308741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients.
    Leroyer C; Mercier B; Oger E; Chenu E; Abgrall JF; Férec C; Mottier D
    Thromb Haemost; 1998 Jul; 80(1):49-51. PubMed ID: 9684784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
    Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
    Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ; Zöller B; Dahlbäck B
    Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis.
    Svensson PJ; Zöller B; Mattiasson I; Dahlbäck B
    J Intern Med; 1997 May; 241(5):379-85. PubMed ID: 9183305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
    Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
    Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
    Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population.
    Souto JC; Coll I; Llobet D; del Río E; Oliver A; Mateo J; Borrell M; Fontcuberta J
    Thromb Haemost; 1998 Sep; 80(3):366-9. PubMed ID: 9759610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
    Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
    Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The factor V gene A4070G mutation and the risk of venous thrombosis.
    Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
    Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G; Tosetto A; Simioni M; Ruggeri M; Madeo D; Rodeghiero F
    Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes].
    Alvarez A; Barroso A; Robledo M; Arranz E; Outeiriño J; Benítez J
    Sangre (Barc); 1999 Feb; 44(1):7-12. PubMed ID: 10323090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.